Author Archives: Jenn Pichardo

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing education activity is provided by   Support Statement This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. Target Audience The intended audience for this activity is neurologists, neurology nursing professionals, pharmacists, physician assistants, and other health care professionals involved in the management …

Continue reading “Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis”

New Podcasts Available for Clinicians to Earn CE Credit! Earn up to 0.75 CE Credits Sit back and listen to three exciting and insightful podcasts from top MS experts. Featuring discussions on the clinical course of MS (Drs. Fred Lublin and Robert Shin), MS assessment (Drs. Patricia Coyle and Robert Shin), and shared decision-making strategies …

Continue reading “AIMS Peer-to-Peer Podcasts”

This two-part CE webinar series aims to provide guidance on the appropriate use of therapies and strategies for delivering individualized care to patients with multiple sclerosis (MS). This series will incorporate case discussions and a live question-and-answer session.

This two-part CE webinar series aims to provide guidance on the appropriate use of therapies and strategies for delivering individualized care to patients with multiple sclerosis (MS). This series will incorporate case discussions and a live question-and-answer session.

Released: January 11, 2021 Expires: January 11, 2022 Program Description This activity provides an overview of the role of the innate and adaptive immune systems in the development and progression of multiple sclerosis (MS), while exploring the therapeutic implications of immune dysfunction. MS immunotherapies are reviewed, with a focus on their mechanisms of action and …

Continue reading “Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management”

*Canadian HCPs only* Tuesday, Mar 16, 2021 2:00 – 3:00 PM Eastern (11:00 AM Pacific) Intended Audience: Neurology teams (physicians, PAs, NPs, nurses, and pharmacists) providing care for patients with MS Advances in therapeutics have delivered a multitude of treatment options for multiple sclerosis (MS), including multiple S1P-based disease-modifying therapies (DMTs). Tune into this webcast …

Continue reading “Evolving Treatment Paradigms in Multiple Sclerosis: Essential Updates for Neurology Teams”

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration Date: November 30, 2021 Intended Audience: Physicians and their teams providing care for patients with MS (PAs, NPs, nurses, pharmacists) Accompanying this activity are resources to provide evidence-based guidance on necessary laboratory evaluations needed before initiating or switching DMTs, as well as a guide for …

Continue reading “Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights”

Release Date: February 1, 2021 Valid for Credit Through: February 1, 2022 Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis Chantel D. Mayo, MSc*; Negar Farzam-kia, BSc*; Setareh Ghahari, PhD, OT Reg (Ont) Target Audience: The target audience for this activity is physicians, physician assistants, nursing professionals, mental …

Continue reading “IJMSC: Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis”

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …

Continue reading “Examining the Evidence for Early Initiation of Disease-Modifying Therapy”

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …

Continue reading “Exploring the Use of Diagnostic Tools to Improve Early Detection of MS”